Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility
about
Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery.Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes.Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.Polymeric therapeutic delivery systems for the treatment of infectious diseases.
P2860
Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@ast
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@en
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@nl
type
label
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@ast
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@en
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@nl
prefLabel
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@ast
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@en
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@nl
P2093
P2860
P356
P1476
Multivalent antiviral XTEN-pep ...... f-life and enhanced solubility
@en
P2093
Arthur Vasek
Bee-Cheng Sim
Bryant McLaughlin
Chia-Wei Wang
Colin Deniston
M Amanda Hartman
Michael Song
Prathna Srinivas
Rahul Sharan
P2860
P304
P356
10.1021/BC500215M
P577
2014-06-23T00:00:00Z